Identification of new subtypes of breast cancer based on vasculogenic mimicry related genes and a new model for predicting the prognosis of breast cancer

• Published in: Heliyon 2024-09, Vol.10 (17), p.e36565, Article e36565
• Main Authors: Liang, Xiao, Ma, Xinyue, Luan, Feiyang, Gong, Jin, Zhao, Shidi, Pan, Yiwen, Liu, Yijia, Liu, Lijuan, Huang, Jing, An, Yiyang, Hu, Sirui, Yang, Jin, Dong, Danfeng
• Format: Article
• Language: English
• Subjects: Consensus clustering; Immune microenvironment; LAMC2; PIK3CA; TFPI2; Vasculogenic mimicry
• ISSN: 2405-8440; 2405-8440
• DOI: 10.1016/j.heliyon.2024.e36565

Breast cancer is a malignant tumor that poses a serious threat to women's health, and vasculogenic mimicry (VM) is strongly associated with bad prognosis in breast cancer. However, the relationship between VM and immune infiltration in breast cancer and the underlying mechanisms have not been fully studied. On the basis of the Cancer Genome Atlas (TCGA), Fudan University Shanghai Cancer Center (FUSCC) database, GSCALite database, and gene set enrichment analysis (GSEA) datasets, we investigated the potential involvement of VM-related genes in the development and progression of breast cancer. We analyzed the differential expression, mutation status, methylation status, drug sensitivity, tumor mutation burden (TMB), microsatellite instability (MSI), immune checkpoints, tumor microenvironment (TME), and immune cell infiltration levels associated with VM-related genes in breast cancer. We created two VM subclusters out of breast cancer patients using consensus clustering, and discovered that patients in Cluster 1 had better survival outcomes compared to those in Cluster 2. The infiltration levels of T cells CD4 memory resting and T cells CD8 were higher in Cluster 1, indicating an immune-active state in this cluster. Additionally, we selected three prognostic genes (LAMC2, PIK3CA, and TFPI2) using Lasso, univariate, and multivariate Cox regression and constructed a risk model, which was validated in an external dataset. The prognosis of patients is strongly correlated with aberrant expression of VM-related genes, which advances our knowledge of the tumor immune milieu and enables us to identify previously unidentified breast cancer subtypes. This could direct more potent immunotherapy approaches.